Angelini Pharma
Angelini Pharma is a german pharmaceutical subsidiary focused on brain and consumer health.
Analyst Perspective
Angelini Pharma Deutschland GmbH is the German subsidiary of Angelini Pharma S.p.a., a private pharmaceutical company within Angelini Industries. In Germany, it markets prescription and consumer healthcare products with a stated focus on brain health and consumer health. The company is not an adtech or software vendor; it is a pharmaceutical operating business that also uses digital assets to support channel relationships and health education. Its revenue comes primarily from pharmaceutical and consumer health product sales through healthcare and pharmacy channels, supported by market-specific distribution and reimbursement structures. The company’s proprietary digital products play supporting roles: Angelini Pharma PLUS+ strengthens pharmacy engagement through training and order visibility, while Harmonia Mentis functions as an educational content hub for patients, caregivers and healthcare professionals, reinforcing disease awareness and brand engagement rather than acting as core standalone revenue drivers.
Analyst Signal Briefing
Updated: 3 Jul 2026No strategic news signals detected in the last 90 days.
Explorer Tier
Start exploring for free
Start with public company intelligence. Save companies, build your first watchlist, and unlock deeper strategic insights when you are ready.
- View public Company Profiles
- Save/watch companies
- Build your first Watchlist
- Access additional market signals
Key insights about Angelini Pharma
Category Differentiation
This company is a German pharmaceutical operating subsidiary, not a standalone software vendor or advertising technology platform. Its digital products support pharmacy engagement and health education rather than constituting its primary business.
Angelini Pharma: About
The company creates value by commercialising prescription medicines and consumer healthcare products in Germany under the Angelini Pharma portfolio. It combines pharmaceutical sales, channel management and medical-market education with proprietary digital tools that improve pharmacy relationships, operational coordination and patient engagement. The core economic engine is product distribution through healthcare channels, while digital platforms deepen access, retention and market visibility.
How Angelini Pharma Works & Monetises
Business model analysis and core revenue streams
Angelini Pharma Deutschland monetises primarily through one-off product sales of prescription medicines and consumer healthcare products via wholesale, pharmacy and healthcare channels. Pricing is governed by standard pharmaceutical commercial mechanics, including distribution margins and reimbursement-linked market access where applicable. Its digital assets are support layers rather than core paid software products: PLUS+ strengthens pharmacy retention and ordering relationships, and Harmonia Mentis supports awareness and demand generation for brain health categories.
Revenue Channels
Products & Services in Categories
Verified structural categorizations from the graph
Media Channel
Angelini Pharma: Frequently Asked Questions
What is Angelini Pharma?
Angelini Pharma is the German subsidiary of Angelini Pharma S.p.a., focused on prescription and consumer healthcare products, especially in brain health and consumer health.
Who uses Angelini Pharma?
Its direct customers include pharmacists, pharmacy businesses, healthcare professionals and distribution partners, while patients and caregivers use its educational content platforms.
How does Angelini Pharma make money?
It makes money primarily from selling prescription medicines and consumer healthcare products through regulated healthcare and pharmacy channels.
Company Facts
- Headquarters
- Germany
- Core Segment
- Other / Non-Digital Advertising Relevant
- Company Size
- 50–200
- Official Link
- angelinipharma.de